Search

everythinglearnresearchcommunity

for

Search:↓

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Dang Gui may help treat immune-related diseases by boosting and regulating the immune system.

Yangyin Qingre Huoxue Prescription may help treat atherosclerosis with fewer liver side effects than simvastatin.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Leptin, a hormone, is important for starting hair growth.

Leptin helps start the growth phase of hair.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Signaling pathways are key targets for developing effective drugs.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

Natural products can help overcome cancer drug resistance.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.